StockData

IB Acquisition Corp. (IBAC) stock

IBACNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBACR
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$10.85+0.00 (0.00%)

Close on Nov 18, 2026Market cap $54.34MP/E –Yield –

IB Acquisition operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

IB Acquisition's operating income for the twelve months ending Jun 30, 2026 was -$1.79M. For fiscal 2025 it was -$748.91K.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$748.91K–
FY2024Sep 30, 2024-$523.97K–
FY2023Sep 30, 2023-$6.84K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$624.43K–
Q2 FY2026CQ1 2026Mar 31, 2026-$748.18K–
Q1 FY2026CQ4 2025Dec 31, 2025-$180.00K–
Q4 FY2025CQ3 2025Sep 30, 2025-$236.77K–
Q3 FY2025CQ2 2025Jun 30, 2025-$172.21K–
Q2 FY2025CQ1 2025Mar 31, 2025-$163.49K–
Q1 FY2025CQ4 2024Dec 31, 2024-$176.44K–
Q4 FY2024CQ3 2024Sep 30, 2024-$165.46K–
Q3 FY2024CQ2 2024Jun 30, 2024-$76.38K–
Q2 FY2024CQ1 2024Mar 31, 2024-$194.65K–
Q1 FY2024CQ4 2023Dec 31, 2023-$87.49K–
Q4 FY2023CQ3 2023Sep 30, 2023-$6.70K–
Q3 FY2023CQ2 2023Jun 30, 2023-$48–
Q2 FY2023CQ1 2023Mar 31, 2023-$48–

More IB Acquisition figures

See a number that looks wrong?